about
Recent advances in the treatment of melanoma with BRAF and MEK inhibitorsMRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the BrainEnhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.Afatinib in Treatment-Naive Patients With EGFR-Mutated Lung Adenocarcinoma With Brain Metastasis: A Case Series.Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levelsCAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype.Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.Stereotactic radiosurgery for multiple brain metastases.The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.Brain metastases: an overview.Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study.Brain metastasis: Unique challenges and open opportunities.New protein kinase inhibitors in breast cancer: afatinib and neratinib.Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.A framework for understanding and targeting residual disease in oncogene-driven solid cancers.Imaging and clinical end points in brain metastases trials.Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.Comparing available criteria for measuring brain metastasis response to immunotherapy.Best Practices in Treatment Selection for Patients With Advanced NSCLC.Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.Mechanisms and Therapy for Cancer Metastasis to the Brain.Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.
P2860
Q26778769-2326E7B9-4817-43D6-A9FF-40F9A29CFD0DQ29248327-4C64EF9B-B093-465C-8D38-BB3579F713EEQ35011982-3148FD43-2707-472B-AC0B-B7E685E5E8EDQ36195658-3A7B623D-A061-45F7-8230-F6BAAD894B90Q36498760-B5D922B4-F0AE-4164-9AF2-FDEFD60F2DEBQ36557389-59EE703F-203E-46AE-96B0-49529D51EC4AQ36600202-1704F2AD-842D-41B4-8ECA-B216B85D894CQ38230692-ECE52731-62A8-4970-A0F3-7628E85A27D8Q38289478-0D31D96F-B282-4979-A7EC-EAF4E30220A2Q38317417-CE0027F6-DFD7-42A6-8958-F16B4B6637B0Q38715328-9D099FAD-A9E1-4757-8DCC-9E5646FDD620Q38819317-A3B76CC3-D061-4D9A-BA4A-F334EA401BA4Q39035128-7B4CC71C-67F1-4B15-8D48-13566D6A469DQ39200319-BB24CFBC-3B86-4006-AAE2-995C76E5213FQ41636267-764C9B23-47BB-4261-9FFB-1BD0D1B93671Q41908997-495C8917-46BD-473E-9C0E-9CE57A2AB056Q48031513-72EB769D-18D3-4F40-9254-7CC85F93C271Q48088530-0D6614ED-64C5-48B0-A488-359B40BAEEC6Q48272048-3D54AD76-181F-40BD-8A23-0F58221C8FE9Q52814108-DC3DF1D3-79EA-4D6A-987F-0232E2ECA03BQ54942435-7DCC2B2B-8FB8-4FD9-BEFD-C5F142ABBCE9Q54950354-C3731552-A76E-44EC-8836-F515E12937E8Q54982136-F4BC88E8-EA48-46BF-B68D-CC424E11546B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted therapies in brain metastases.
@en
Targeted therapies in brain metastases.
@nl
type
label
Targeted therapies in brain metastases.
@en
Targeted therapies in brain metastases.
@nl
prefLabel
Targeted therapies in brain metastases.
@en
Targeted therapies in brain metastases.
@nl
P2860
P1476
Targeted therapies in brain metastases.
@en
P2093
Nancy U Lin
P2860
P2888
P356
10.1007/S11940-013-0276-Z
P577
2014-01-01T00:00:00Z